2-Cyclopropyl-5-methoxypyrimidine

Catalog No.: 
ACHRIA675
CAS No.: 
1956326-84-3
Molecular Formula: 
C8H10N2O
Molecular Weight: 
150.18
2-Cyclopropyl-5-methoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$202.00InquiryInquiry
250mg97%$395.00InquiryInquiry
1g97%$1196.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyclopropyl-5-methoxypyrimidine
IUPAC Name2-cyclopropyl-5-methoxypyrimidine
Molecular FormulaC8H10N2O
Molecular Weight150.18
SMILESCOC1=CN=C(C2CC2)N=C1
InChI KeyOYBNLRZNWNWJCL-UHFFFAOYSA-N
SynonymPyrimidine, 2-cyclopropyl-5-methoxy-
CAS No.1956326-84-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHRIA675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBYQR560 route compound structure diagram
    ACBYQR56022536-65-8In Stock
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACHRIA675 route product structure diagram
    ACHRIA6751956326-84-3
Inquiry

2. ACHRIA675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBYQR560 route compound structure diagram
    ACBYQR56022536-65-8In Stock
  4. Then
  5. ACHRIA675 route product structure diagram
    ACHRIA6751956326-84-3
Inquiry

3. ACHRIA675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBYQR560 route compound structure diagram
    ACBYQR56022536-65-8In Stock
  4. Then
  5. ACHRIA675 route product structure diagram
    ACHRIA6751956326-84-3
Inquiry

Comments (0)